These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35791948)

  • 81. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases.
    Al-Mousa H; Abouelhoda M; Monies DM; Al-Tassan N; Al-Ghonaium A; Al-Saud B; Al-Dhekri H; Arnaout R; Al-Muhsen S; Ades N; Elshorbagi S; Al Gazlan S; Sheikh F; Dasouki M; El-Baik L; Elamin T; Jaber A; Kheir O; El-Kalioby M; Subhani S; Al Idrissi E; Al-Zahrani M; Alhelale M; Alnader N; Al-Otaibi A; Kattan R; Al Abdelrahman K; Al Breacan MM; Bin Humaid FS; Wakil SM; Alzayer F; Al-Dusery H; Faquih T; Al-Hissi S; Meyer BF; Hawwari A
    J Allergy Clin Immunol; 2016 Jun; 137(6):1780-1787. PubMed ID: 26915675
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ending a Diagnostic Odyssey: Family Education, Counseling, and Response to Eventual Diagnosis.
    Basel D; McCarrier J
    Pediatr Clin North Am; 2017 Feb; 64(1):265-272. PubMed ID: 27894449
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Diagnostic yield of next-generation sequencing applied to neurological disorders.
    Marques Matos C; Alonso I; Leão M
    J Clin Neurosci; 2019 Sep; 67():14-18. PubMed ID: 31272831
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Scaling genetic resources: New paradigms for diagnosis and treatment of rare genetic disease.
    Vockley J; Defay T; Goldenberg AJ; Gaviglio AM
    Am J Med Genet C Semin Med Genet; 2023 Mar; 193(1):77-86. PubMed ID: 36448938
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Nonhuman primate genetic models for the study of rare diseases.
    Vallender EJ; Hotchkiss CE; Lewis AD; Rogers J; Stern JA; Peterson SM; Ferguson B; Sayers K
    Orphanet J Rare Dis; 2023 Jan; 18(1):20. PubMed ID: 36721163
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Gene-targeted therapies: Towards equitable development, diagnosis, and access.
    Gaviglio AM; Skinner MW; Lou LJ; Finkel RS; Augustine EF; Goldenberg AJ
    Am J Med Genet C Semin Med Genet; 2023 Mar; 193(1):56-63. PubMed ID: 36688577
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Management of genetic renal disorders: local experience and importance of the network].
    Bonny O; Ketterer A; Hermida S; Superti-Furga A; Venetz JP; Chehade H; Fodstad H; Cina V; Parvex P; Paoloni-Giacobino A; De Seigneux S; Fakhouri F
    Rev Med Suisse; 2023 Jun; 19(832):1245-1249. PubMed ID: 37341318
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A Practical Guide to Genetic Testing for Kidney Disorders of Unknown Etiology.
    Aron AW; Dahl NK; Besse W
    Kidney360; 2022 Sep; 3(9):1640-1651. PubMed ID: 36245662
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Diagnosis of uncertain significance: can next-generation sequencing replace the clinician?
    Ashton E; Bockenhauer D
    Kidney Int; 2020 Mar; 97(3):455-457. PubMed ID: 32087887
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Rare Renal Diseases Can Be Used as Tools to Investigate Common Kidney Disorders.
    Simeoni M; Damiano S; Capolongo G; Trepiccione F; Zacchia M; Fuiano G; Capasso G
    Kidney Dis (Basel); 2017 Jul; 3(2):43-49. PubMed ID: 28868291
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Power of Clinical Diagnosis for Deciphering Complex Genetic Mechanisms in Rare Diseases.
    Shu L; Maroilley T; Tarailo-Graovac M
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672937
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Genetics of Kidney Disease: The Unexpected Role of Rare Disorders.
    Elliott MD; Rasouly HM; Gharavi AG
    Annu Rev Med; 2023 Jan; 74():353-367. PubMed ID: 36375470
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment.
    Relton CL; Davey Smith G
    PLoS Med; 2010 Oct; 7(10):e1000356. PubMed ID: 21048988
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Improving diagnostics of rare genetic diseases with NGS approaches.
    Vinkšel M; Writzl K; Maver A; Peterlin B
    J Community Genet; 2021 Apr; 12(2):247-256. PubMed ID: 33452619
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Genomic testing for rare disease diagnosis-where are we now, and where should we be heading? The reflections of a behavioural scientist.
    Lewis C
    Eur J Hum Genet; 2023 Nov; 31(11):1204-1206. PubMed ID: 37528189
    [No Abstract]   [Full Text] [Related]  

  • 96. Are we prepared to deliver gene-targeted therapies for rare diseases?
    Yu TW; Kingsmore SF; Green RC; MacKenzie T; Wasserstein M; Caggana M; Gold NB; Kennedy A; Kishnani PS; Might M; Brooks PJ; Morris JA; Parisi MA; Urv TK
    Am J Med Genet C Semin Med Genet; 2023 Mar; 193(1):7-12. PubMed ID: 36691939
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Realizing the Potential of Gene Therapies for Rare and Ultra-Rare Inherited Diseases.
    Booth C; Aiuti A
    Hum Gene Ther; 2023 Sep; 34(17-18):776-781. PubMed ID: 37624746
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Data sharing to advance gene-targeted therapies in rare diseases.
    Lekstrom-Himes J; Augustine EF; Brower A; Defay T; Finkel RS; McGuire AL; Skinner MW; Yu TW
    Am J Med Genet C Semin Med Genet; 2023 Mar; 193(1):87-98. PubMed ID: 36594517
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Rare diseases: democratising genetic testing in LMICs.
    Núñez-Samudio V; Arcos-Burgos M; Landires I
    Lancet; 2023 Apr; 401(10385):1339-1340. PubMed ID: 37087169
    [No Abstract]   [Full Text] [Related]  

  • 100. 2022: a pivotal year for diagnosis and treatment of rare genetic diseases.
    Kingsmore SF
    Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 35217563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.